BCL6 and diffuse large B-cell lymphoma: The significantly worse outcome in patients with double-hit and triple-hit DLBCL may include both synergistic action of c-MYC and BCL2/BCL6 as well as other molecular features originating from the more numerous genetic aberrations in double-hit and triple-hit DLBCL [151, 152].